๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Merkel Cell Carcinoma

TIL Therapy in cSCC and MCC NCT07288073Phase 21 site๐Ÿ“ Boston Karam Khaddour, MD, MS ยท Tests: LN-145, Cyclophosphamide, Fludarabine, Interleukin-2 Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors NCT07006727Phase 18 sites๐Ÿ“ Iowa City๐Ÿ“ Boston๐Ÿ“ Royal Oak Novartis Pharmaceuticals ยท Tests: 225Ac-ETN029, 111In-ETN029 A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors NCT07749586Phase 1, Phase 24 sites๐Ÿ“ New York๐Ÿ“ Huntersville๐Ÿ“ San Antonio Arvinas Inc. ยท Tests: ARV-6723, Pembrolizumab, SOC Hypofractionated Radiation Therapy for Merkel Cell Carcinoma NCT05100095Phase 21 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Radiation therapy Phase II Study of Peptide Receptor Radionuclide Therapy in Combination With Immunotherapy for Patients With Merkel Cell Cancer NCT05583708Phase 24 sites๐Ÿ“ Duarte๐Ÿ“ Iowa City๐Ÿ“ New York Weill Medical College of Cornell University ยท Tests: Pembrolizumab, Lutetium Lu 177 dotatate The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas NCT07285044Phase 21 site๐Ÿ“ Jacksonville Mayo Clinic ยท Tests: Cancer Therapeutic Procedure, Cancer Therapeutic Procedure, Questionnaire Administration A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors NCT05592626Phase 1, Phase 219 sites๐Ÿ“ Sacramento๐Ÿ“ Celebration๐Ÿ“ Miami Marengo Therapeutics, Inc. ยท Tests: STAR0602, Irinotecan (Camptosar), Docetaxel (Taxotere) Neoadjuvant PD-1 Blockade in Resectable Merkel Cell Carcinoma NCT05496036Phase 21 site๐Ÿ“ Philadelphia Abramson Cancer Center at Penn Medicine ยท Tests: Pembrolizumab A Study of VET3-TGI in Patients With Solid Tumors NCT06444815Phase 17 sites๐Ÿ“ Los Angeles๐Ÿ“ Orange๐Ÿ“ Miami KaliVir Immunotherapeutics ยท Tests: VET3-TGI, Atezolizumab Studying Off Label Insurance Coverage for Patients With Cutaneous Cancers a "Filter" Observational Study NCT07215988n/a1 site๐Ÿ“ Columbus Ohio State University Comprehensive Cancer Center ยท Tests: Non-Interventional Study A First-in-Human Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of KUP-101A in Patients With Selected Advanced Solid Tumors NCT07600476Phase 13 sites๐Ÿ“ Munich๐Ÿ“ Wรผrzburg๐Ÿ“ Mรผnster Kupando GmbH ยท Tests: KUP-101A A Study of CRD3874-SI in People With Solid Tumors NCT06021626Phase 17 sites๐Ÿ“ Basking Ridge๐Ÿ“ Middletown๐Ÿ“ Montvale Memorial Sloan Kettering Cancer Center ยท Tests: CRD3874 French National Database of Rare Dermatological Cancers NCT03210935n/a34 sites๐Ÿ“ Dijon๐Ÿ“ Le Mans๐Ÿ“ Pierre-Bรฉnite University Hospital, Lille Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rฮฑ Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer NCT05267626Phase 1, Phase 217 sites๐Ÿ“ Miami๐Ÿ“ Grand Rapids๐Ÿ“ Minneapolis Aulos Bioscience, Inc. ยท Tests: AU-007, Aldesleukin, Avelumab, Nivolumab Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus NCT02479698Phase 21 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Allogeneic BK-specific Cytotoxic T-lymphocytes, Laboratory Biomarker Analysis A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer NCT05859074Phase 17 sites๐Ÿ“ Basking Ridge๐Ÿ“ Middletown๐Ÿ“ Montvale Memorial Sloan Kettering Cancer Center ยท Tests: MQ719, Pembrolizumab MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors NCT05076760Phase 12 sites๐Ÿ“ Tampa๐Ÿ“ Durham Memgen, Inc. ยท Tests: MEM-288 Intratumoral Injection, Nivolumab, Docetaxel Personalised Immunotherapy Platform NCT06536257n/a3 sites๐Ÿ“ Sydney๐Ÿ“ Sydney๐Ÿ“ Sydney Melanoma Institute Australia ยท Tests: Predictive model Validation of in Vitro Method for Anti-MCPyV Immunotherapy on Patients With Cutaneous Merkel Cell Carcinoma NCT06780475n/a1 site๐Ÿ“ Boulogne-Billancourt Assistance Publique - Hรดpitaux de Paris Sentinel Lymph Node Biopsy in Ocular Surface and Adnexal Cancers NCT05797415n/a1 site๐Ÿ“ Roma Fondazione Policlinico Universitario Agostino Gemelli IRCCS ยท Tests: Sentinel Lymph Node Biopsy EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers NCT06223659Phase 21 site๐Ÿ“ Columbus Ohio State University Comprehensive Cancer Center ยท Tests: Eutectic Mixture of Local Anesthetics, Placebo Administration, Questionnaire Administration Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype NCT06753136NA1 site๐Ÿ“ Padova Istituto Oncologico Veneto IRCCS ยท Tests: percutaneous, laparoscopic or laparotomy lesion electrochemotherapy Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer NCT05896839Phase 1, Phase 226 sites๐Ÿ“ La Jolla๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles National Cancer Institute (NCI) ยท Tests: Biopsy Procedure, Biospecimen Collection, Computed Tomography, Ipilimumab, Kidney Biopsy Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors NCT06814496Phase 1, Phase 23 sites๐Ÿ“ Gilbert๐Ÿ“ Tucson๐Ÿ“ Seattle University of Arizona ยท Tests: Tarlatamab, Concurrent Radiation Therapy, Sequential Radiation therapy Neoadjuvant Merkel Cell Carcinoma Therapy (Tx) With the PD-1 Inhibitor Cemiplimab NCT07387198Phase 214 sites๐Ÿ“ Heidelberg๐Ÿ“ Mannheim๐Ÿ“ Tรผbingen Institut fรผr Klinische Krebsforschung IKF GmbH at Krankenhaโ€ฆ ยท Tests: Cemiplimab 350 mg i.v. on day 1 of every 21 days cycle for 2 cycles, Placebo NaCl 0.9% solution i.v. on day 1 of every โ€ฆ Neoadjuvant Nivolumab and Relatlimab in Merkel Cell Carcinoma NCT06151236Phase 21 site๐Ÿ“ Wollstonecraft Melanoma Institute Australia ยท Tests: Nivolumab 240 mg / Relatlimab 80 mg in a fixed dose combination Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma NCT04975152Phase 11 site๐Ÿ“ Tampa H. Lee Moffitt Cancer Center and Research Institute ยท Tests: Cemiplimab-Rwlc Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors NCT05269381Phase 1, Phase 21 site๐Ÿ“ Jacksonville Mayo Clinic ยท Tests: Cyclophosphamide, Neoantigen Peptide Vaccine, Pembrolizumab, Sargramostim, Biospecimen Collection A Beta-only IL-2 ImmunoTherapY Study NCT05086692Phase 1, Phase 228 sites๐Ÿ“ San Diego๐Ÿ“ San Francisco๐Ÿ“ Santa Monica Medicenna Therapeutics, Inc. ยท Tests: MDNA11, Pembrolizumab (KEYTRUDAยฎ) Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors NCT07080242Phase 124 sites๐Ÿ“ Huntsville๐Ÿ“ Glendale๐Ÿ“ Long Beach SystImmune Inc. ยท Tests: BL-M14D1
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy